NDAINJECTIONINJECTABLE
Lifecycle
Pre-Launch
Clinical Trials
1
Data completeness
3/8 — Basic
HYDROXYPROGESTERONE CAPROATE (hydroxyprogesterone caproate) by Aspen Surgical is clinical pharmacology hydroxyprogesterone is a potent, long-acting, progestational steroid ester which transforms proliferative endothelium into secretory endothelium, induces mammary gland duct development, and inhibits the production and/or release of gonadotropic hormone; it also shows slight estrogenic, androgenic, or corticoid effects as well, but should not be relied upon for these effects.
Drug data last refreshed 1h ago · AI intelligence enriched 6d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Hydroxyprogesterone caproate is a long-acting progestational steroid ester administered via intramuscular injection. It transforms endometrial tissue, induces mammary gland development, and inhibits gonadotropic hormone production, with demonstrated efficacy in advanced uterine corpus adenocarcinoma and prevention of preterm birth. The drug works through potent progestational activity with peak serum levels appearing 3–7 days post-injection.
$0.02BPart D
Pre-LaunchPre-launch status with minimal current spending indicates a product in early commercial phase; brand and launch teams will be building infrastructure and market access strategies.
Mechanism of Action
CLINICAL PHARMACOLOGY Hydroxyprogesterone is a potent, long-acting, progestational steroid ester which transforms proliferative endothelium into secretory endothelium, induces mammary gland duct development, and inhibits the production and/or release of gonadotropic hormone; it also shows slight…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Worked on HYDROXYPROGESTERONE CAPROATE at Aspen Surgical? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.